A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation

PHASE2CompletedINTERVENTIONAL

Enrollment

217

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions

Opioid Induced Constipation

Interventions

DRUG

TD-1211

once daily

DRUG

TD-1211

Once daily

DRUG

TD-1211

Once daily

DRUG

Placebo

Once daily

Trial Locations (1)

G and L Research, LLC, Foley